Register Login
Register to leave comments
  • News bot April 20, 2026, 10:22 a.m.

    📋 MONOPAR THERAPEUTICS (MNPR) - Clinical Trial Update

    Filing Date: 2026-04-20

    Accepted: 2026-04-20 06:22:12

    Event Type: Clinical Trial Update

    Event Details:

    MONOPAR THERAPEUTICS (MNPR) Announces Clinical Trial Update MONOPAR THERAPEUTICS (MNPR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: patients, treatments
    • Clinical Stage: Phase 3
    • Collaboration: AAN

    🔬 Clinical Development Pipeline (MONOPAR THERAPEUTICS):

    Product Type Development Stage Therapeutic Area Source
    MNPR-101-PCTA-177Lu BIOLOGICAL Preclinical Cancer ClinicalTrials.gov
    MNPR-101-DFO*-89Zr DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Camsirubicin DRUG Phase PHASE1 Advanced Soft-tissue Sarcoma ClinicalTrials.gov
    Placebo Mucoadhesive Buccal Tablet DRUG Phase PHASE2 Chemoradiotherapy-Induced Severe Oral Mucositis ClinicalTrials.gov
    Clonidine HCl Mucoadhesive Buccal Tablet DRUG Phase PHASE2 Chemoradiotherapy-Induced Severe Oral Mucositis ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MONOPAR THERAPEUTICS
    • Ticker Symbol: MNPR

Search

News categories